Tim Ulinski
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Tim Ulinski has a total of 137 co-authors. Here are the top co-authors by number of shared publications:
- Georges Deschênes
Service de néphrologie pédiatrique, Hôpital Robert Debré, AP-HP, Paris, France
14 shared publications Albert Bensman
Service de Néphrologie et Dialyse Pédiatrique, Assistance Publique-Hôpitaux de Paris and Inflammation-Immunopathology-Biotherapy Department (DHU i2B), Hôpital Armand Trousseau, Paris, France
13 shared publicationsBilal Aoun
Department of Paediatrics, Division of Pediatric Nephrology, American University of Beirut, Beirut, Lebanon
11 shared publicationsElena Tudorache
Department of Paediatric Nephrology, Armand-Trousseau Hospital, APHP, Paris, France
6 shared publicationsJulien Hogan
Pediatric Nephrology, Robert Debré Hospital, APHP, Paris, France
6 shared publicationsAnne-Laure Sellier-Leclerc
Department of Pediatric Nephrology; Armand-Trousseau Hospital; AP-HP; Paris; France
4 shared publications
Latest Publications
- 13 September 2019
- Published by Springer Nature in Pediatric Nephrology
- Vol. 34 (12) , 2605-2608
Infrequent tacrolimus-induced nephrotoxicity in French patients with steroid-dependent nephrotic syndrome
Chronic nephrotoxicity with potentially irreversible lesions is a major concern regarding calcineurin inhibitor (CNI) treatment in children with severe forms of idiopathic nephrotic syndrome (INS).
- 13 September 2019
- Published by Springer Nature in Pediatric Nephrology
- Vol. 34 (12) , 2605-2608
Infrequent tacrolimus-induced nephrotoxicity in French patients with steroid-dependent nephrotic syndrome
Chronic nephrotoxicity with potentially irreversible lesions is a major concern regarding calcineurin inhibitor (CNI) treatment in children with severe forms of idiopathic nephrotic syndrome (INS).
- 12 December 2018
- Published by Springer Nature in Pediatric Nephrology
- Vol. 34 (3) , 529-532
Idiopathic nephrotic syndrome and rituximab: may we predict circulating B lymphocytes recovery?
Rituximab (RTX) has been shown to be an efficient treatment for steroid-dependent nephrotic syndrome (SDNS). A long B cell depletion period seems to improve the duration of remission. This study reports the duration of B cell depletion after each RTX infusion in patients with nephrotic syndrome.
- 12 December 2018
- Published by Springer Nature in Pediatric Nephrology
- Vol. 34 (3) , 529-532
Idiopathic nephrotic syndrome and rituximab: may we predict circulating B lymphocytes recovery?
Rituximab (RTX) has been shown to be an efficient treatment for steroid-dependent nephrotic syndrome (SDNS). A long B cell depletion period seems to improve the duration of remission. This study reports the duration of B cell depletion after each RTX infusion in patients with nephrotic syndrome.
- Open Access
- 16 July 2018
- Published by Springer Nature in Journal of Medical Case Reports
- Vol. 12 (1) , 209
Distinctive vasculopathy with systemic involvement due to levamisole long-term therapy: a case report
Levamisole belongs to the antihelminthic class of drugs that are sometimes administered to patients with frequently relapsing or steroid-dependent nephrotic syndrome, owing to its steroid-sparing effects. Neutropenia and skin lesions, compatible with vasculitis, have been reported as drug complications, but they are rarely associated with any systemic involvement. We report a case of a 9-year-old Arab boy with steroid-dependent nephrotic syndrome who was treated with levamisole after his third relapse. The drug was initially well tolerated, but mild isolated neutropenia occurred 6 months after levamisole administration. This was followed by cutaneous vasculitis of both ears and the left cheek. The patient also developed hepatosplenomegaly and anemia. Levamisole was discontinued, and his disease remained in remission. All the systemic manifestations disappeared gradually over the course of 1 month. The patient remained in remission until 1 year after levamisole withdrawal, when clinical nephrosis recurred. Despite levamisole’s being a useful drug for maintaining remission in steroid-dependent nephrotic syndrome, patients on long-term levamisole therapy should be monitored closely to prevent serious complications that can easily be resolved by simple drug withdrawal.
- 16 July 2018
- Published by Springer Nature in Journal of Medical Case Reports
- Vol. 12 (1) , 209
Open AccessDistinctive vasculopathy with systemic involvement due to levamisole long-term therapy: a case report
Levamisole belongs to the antihelminthic class of drugs that are sometimes administered to patients with frequently relapsing or steroid-dependent nephrotic syndrome, owing to its steroid-sparing effects. Neutropenia and skin lesions, compatible with vasculitis, have been reported as drug complications, but they are rarely associated with any systemic involvement. We report a case of a 9-year-old Arab boy with steroid-dependent nephrotic syndrome who was treated with levamisole after his third relapse. The drug was initially well tolerated, but mild isolated neutropenia occurred 6 months after levamisole administration. This was followed by cutaneous vasculitis of both ears and the left cheek. The patient also developed hepatosplenomegaly and anemia. Levamisole was discontinued, and his disease remained in remission. All the systemic manifestations disappeared gradually over the course of 1 month. The patient remained in remission until 1 year after levamisole withdrawal, when clinical nephrosis recurred. Despite levamisole’s being a useful drug for maintaining remission in steroid-dependent nephrotic syndrome, patients on long-term levamisole therapy should be monitored closely to prevent serious complications that can easily be resolved by simple drug withdrawal.
- 1 December 2017
- Published by Elsevier in Archives de Pédiatrie
- Vol. 24 (12) , 1328-1329
Pre-emptive kidney transplantation is associated with improved graft survival in children: Data from the French renal replacement therapy registry
- 1 December 2017
- Published by Elsevier in Archives de Pédiatrie
- Vol. 24 (12) , 1328-1329
Pre-emptive kidney transplantation is associated with improved graft survival in children: Data from the French renal replacement therapy registry
- 1 December 2017
- Published by Elsevier in Archives de Pédiatrie
- Vol. 24 (12) , 1329
Cytomegalovirus prophylaxis after kidney transplantation in children: Longer is better
- 1 December 2017
- Published by Elsevier in Archives de Pédiatrie
- Vol. 24 (12) , 1329
Cytomegalovirus prophylaxis after kidney transplantation in children: Longer is better
- 27 September 2017
- Published by Taylor & Francis in Expert Opinion on Pharmacotherapy
- Vol. 18 (15) , 1619-1625
An update on new antibiotic prophylaxis and treatment for urinary tract infections in children
Introduction: This review focuses on the treatment of urinary tract infections (UTI) in children and in particular its recent changes. Areas covered: Acute pyelonephritis, acute cystitis and asymptomatic bacteriuria or asymptomatic infections have to be clearly distinguished. Prompt treatment is required in pyelonephritis and cystitis, but not in asymptomatic bacteriuria or infection, in order to avoid selection of more virulent strains. This concept should be considered even in immunocompromised or bedridden children. In case of pyelonephritis, there should be no delay in beginning the antibiotic treatment in order to decrease the risk of long term complication, such as renal scars. Predisposing conditions for UTI, such as voiding anomalies and urinary tract malformation should be carefully evaluated. Expert opinion: One major concern is the increasing resistance to 3rd generation cephalosporins. Therefore overconsumption in low-risk settings should be absolutely avoided. The prevalence of infections with E. coli producing extended spectrum ß-lactamase (ESBL) is increasing and pediatricians should be aware about the specific treatment options. Any recommendation about (initial) antibiotic treatment should be regularly updated and adapted to local resistance profiles and to economic factors in different health systems.
- 27 September 2017
- Published by Taylor & Francis in Expert Opinion on Pharmacotherapy
- Vol. 18 (15) , 1619-1625
An update on new antibiotic prophylaxis and treatment for urinary tract infections in children
Introduction: This review focuses on the treatment of urinary tract infections (UTI) in children and in particular its recent changes. Areas covered: Acute pyelonephritis, acute cystitis and asymptomatic bacteriuria or asymptomatic infections have to be clearly distinguished. Prompt treatment is required in pyelonephritis and cystitis, but not in asymptomatic bacteriuria or infection, in order to avoid selection of more virulent strains. This concept should be considered even in immunocompromised or bedridden children. In case of pyelonephritis, there should be no delay in beginning the antibiotic treatment in order to decrease the risk of long term complication, such as renal scars. Predisposing conditions for UTI, such as voiding anomalies and urinary tract malformation should be carefully evaluated. Expert opinion: One major concern is the increasing resistance to 3rd generation cephalosporins. Therefore overconsumption in low-risk settings should be absolutely avoided. The prevalence of infections with E. coli producing extended spectrum ß-lactamase (ESBL) is increasing and pediatricians should be aware about the specific treatment options. Any recommendation about (initial) antibiotic treatment should be regularly updated and adapted to local resistance profiles and to economic factors in different health systems.
- 15 August 2017
- Published by Springer Nature in Pediatric Nephrology
- Vol. 33 (6) , 985-986
Thrombotic microangiopathy and breastfeeding: where is the link? Questions
- 15 August 2017
- Published by Springer Nature in Pediatric Nephrology
- Vol. 33 (6) , 985-986
Thrombotic microangiopathy and breastfeeding: where is the link? Questions
- 15 August 2017
- Published by Springer Nature in Pediatric Nephrology
- Vol. 33 (6) , 987-989
Thrombotic microangiopathy and breastfeeding: where is the link? Answers
- 15 August 2017
- Published by Springer Nature in Pediatric Nephrology
- Vol. 33 (6) , 987-989
Thrombotic microangiopathy and breastfeeding: where is the link? Answers
- 15 February 2017
- Published by Springer Nature in Pediatric Nephrology
- Vol. 32 (7) , 1193-1199
Clinical outcomes in children with Henoch–Schönlein purpura nephritis without crescents
Henoch–Schönlein purpura is the most common vasculitis in children. Its long-term prognosis depends on renal involvement. The management of Henoch–Schönlein purpura nephritis (HSPN) remains controversial. This study reports the prognosis of children with HSPN presenting with class 2 International Study of Kidney Disease in Children (ISKDC) nephritis.
- 15 February 2017
- Published by Springer Nature in Pediatric Nephrology
- Vol. 32 (7) , 1193-1199
Clinical outcomes in children with Henoch–Schönlein purpura nephritis without crescents
Henoch–Schönlein purpura is the most common vasculitis in children. Its long-term prognosis depends on renal involvement. The management of Henoch–Schönlein purpura nephritis (HSPN) remains controversial. This study reports the prognosis of children with HSPN presenting with class 2 International Study of Kidney Disease in Children (ISKDC) nephritis.
- 1 December 2016
- Published by Elsevier in Archives de Pédiatrie
- Vol. 23 (12) , 1298
Évolution du SNI de l’enfant : suivi à 5 ans de la cohorte NEPHROVIR
- 1 December 2016
- Published by Elsevier in Archives de Pédiatrie
- Vol. 23 (12) , 1298
Évolution du SNI de l’enfant : suivi à 5 ans de la cohorte NEPHROVIR